Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Sally M. Lansley
Observed names:
S. Lansley,
S. M. Lansley,
S.M. Lansley,
Sally Lansley
Institutions:
The University of Western Australia,
Institute for Respiratory Health
Observed institutions:
The University of Western Australia,
Harry Perkins Institute of Medical Research,
Institute for Respiratory Health
ORCID:
0000-0001-7157-8094
Observed ORCID:
0000-0001-7157-8094
OpenAlex ID:
A5010390663
Mesothelial cells in tissue repair and fibrosis
2015
·
Steven E. Mutsaers
, Kimberly Birnie
, et al.
·
Frontiers in Pharmacology
·
237
PDF
Empyema thoracis: new insights into an old disease
2010
·
F.J.H. Brims
, S.M. Lansley
, et al.
·
European Respiratory Review
·
120
Mesothelial cell differentiation into osteoblast‐ and adipocyte‐like cells
2010
·
Sally M. Lansley
, Richelle G. Searles
, et al.
·
Journal of Cellular and Molecular Medicine
·
79
Tissue Plasminogen Activator Potently Stimulates Pleural Effusion via a Monocyte Chemotactic Protein-1–Dependent Mechanism
2014
·
Sally M. Lansley
, Hui Min Cheah
, et al.
·
American Journal of Respiratory Cell and Molecular Biology
·
50
Combination immune checkpoint blockade as an effective therapy for mesothelioma
2018
·
Vanessa S. Fear
, Caitlin Tilsed
, et al.
·
OncoImmunology
·
48
PDF
First bacteraemic human infection with Escherichia albertii
2015
·
T.J.J. Inglis
, A.J. Merritt
, et al.
·
New Microbes and New Infections
·
42
PDF
Malignant pleural fluid from mesothelioma has potent biological activities
2016
·
Hui Min Cheah
, Sally M. Lansley
, et al.
·
Respirology
·
41
The Origin of Regenerating Mesothelium: A Historical Perspective
2007
·
S.E. Mutsaers
, C. Prêle
, et al.
·
The International Journal of Artificial Organs
·
37
IL-2/CD40-driven NK cells install and maintain potency in the anti-mesothelioma effector/memory phase
2012
·
Connie Jackaman
, Sally Lansley
, et al.
·
International Immunology
·
28
Human pleural fluid is a potent growth medium for Streptococcus pneumoniae
2017
·
Natalia D. Popowicz
, Sally M. Lansley
, et al.
·
PLoS ONE
·
23
PDF
Role of MCP ‐1 in pleural effusion development in a carrageenan‐induced murine model of pleurisy
2016
·
Sally M. Lansley
, Hui Min Cheah
, et al.
·
Respirology
·
18
PPARα and PPARγ activation is associated with pleural mesothelioma invasion but therapeutic inhibition is ineffective
2021
·
M. Lizeth Orozco Morales
, Catherine A. Rinaldi
, et al.
·
iScience
·
13
A commercially available preparation of S taphylococcus aureus bio‐products potently inhibits tumour growth in a murine model of mesothelioma
2014
·
Sally M. Lansley
, Julius F. Varano della Vergiliana
, et al.
·
Respirology
·
13
PDF
Preclinical Assessment of Adjunctive tPA and DNase for Peritoneal Dialysis Associated Peritonitis
2015
·
Amanda L. McGuire
, Sophia C. Bennett
, et al.
·
PLoS ONE
·
12
PDF
Bacterial Infection Elicits Heat Shock Protein 72 Release from Pleural Mesothelial Cells
2013
·
Julius F. Varano della Vergiliana
, Sally M. Lansley
, et al.
·
PLoS ONE
·
12
PDF
Mesothelial cells activate the plasma kallikrein-kinin system during pleural inflammation
2011
·
Julius F. Varano della Vergiliana
, Sally Lansley
, et al.
·
Biological Chemistry
·
9
Streptococcus pneumoniae potently induces cell death in mesothelial cells
2018
·
Rabab Rashwan
, Julius F. Varano della Vergiliana
, et al.
·
PLoS ONE
·
7
PDF
Mesothelioma location influences the tumour microenvironment and immune checkpoint therapy response in preclinical models
2026
·
M. Lizeth Orozco Morales
, Sally M. Lansley
, et al.
·
Scientific Reports
·
2
PDF
Geldanamycin treatment does not result in anti-cancer activity in a preclinical model of orthotopic mesothelioma
2023
·
M. Lizeth Orozco Morales
, Catherine A. Rinaldi
, et al.
·
PLoS ONE
·
2
PDF
A Subset of Malignant Mesothelioma Tumors Retain Osteogenic Potential
2016
·
S. M. Lansley
, B. Pedersen
, et al.
·
Scientific Reports
·
2
PDF
448 (PB436): Deletion of SUZ12 improves cancer cell immunogenicity
2024
·
M.L. Orozco Morales
, K. Farley
, et al.
·
European Journal of Cancer
P2.06-20 Bacteria as Novel Anti-Mesothelioma Agents.
2018
·
S. Lansley
, J. Varano Della Vergiliana
, et al.
·
Journal of Thoracic Oncology
Fibroblast Growth Factor-9 Is Up-Regulated In Malignant Mesothelioma And May Be Involved In The Disease Pathobiology
2012
·
Ai Ling Tan
, Mulugeta Worku
, et al.
·
American Journal of Respiratory and Critical Care Medicine
Fibroblast Growth Factor-9 And Its Potential Biological Role In Malignant Mesothelioma
2011
·
Y.C. G. Lee
, Ai Ling Tan
, et al.
·
American Journal of Respiratory and Critical Care Medicine
The origin and plasticity of mesothelial-derived cells
2008
·
Sally M. Lansley
·
UWA Profiles and Research Repository (University of Western Australia)
PDF
Show more works
View as search
Works count:
25
Citation count:
795
H-index:
13
I10-index:
15
Year
Topic
Type